Literature DB >> 21233718

Novel MLH1 duplication identified in Colombian families with Lynch syndrome.

Virginia Alonso-Espinaco1, María Dolores Giráldez, Carlos Trujillo, Heleen van der Klift, Jenifer Muñoz, Francesc Balaguer, Teresa Ocaña, Irene Madrigal, Angela M Jones, M Magdalena Echeverry, Alejandro Velez, Ian Tomlinson, Montserrat Milà, Juul Wijnen, Luis Carvajal-Carmona, Antoni Castells, Sergi Castellví-Bel.   

Abstract

PURPOSE: Lynch syndrome accounts for 2-4% of all colorectal cancer, and is mainly caused by germline mutations in the DNA mismatch repair genes. Our aim was to characterize the genetic mutation responsible for Lynch syndrome in an extensive Colombian family and to study its prevalence in Antioquia.
METHODS: A Lynch syndrome family fulfilling Amsterdam criteria II was studied by immunohistochemistry and by multiplex ligation-dependent probe amplification (MLPA). Results were confirmed by additional independent MLPA, Southern blotting, and sequencing.
RESULTS: Index case tumor immunohistochemistry results were MLH1-, MSH2+, MSH6+, and PMS2-. MLPA analysis detected a duplication of exons 12 and 13 of MLH1. This mutation was confirmed and characterized precisely to span 4219 base pairs. Duplication screening in this family led to the identification of six additional carriers and 13 noncarriers. We also screened 123 early-onset independent colorectal cancer cases from the same area and identified an additional unrelated carrier.
CONCLUSION: A novel duplication of exons 12 and 13 of the MLH1 gene was detected in two independent Lynch syndrome families from Colombia. A putative founder effect and prescreening Lynch syndrome Antioquia families for this specific mutation before thorough mismatch repair mutational screening could be suggested.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233718     DOI: 10.1097/GIM.0b013e318202e10b

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  7 in total

1.  Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

Authors:  Christina Therkildsen; Anna Isinger-Ekstrand; Steen Ladelund; Anja Nissen; Eva Rambech; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

2.  Lynch syndrome in South America: past, present and future.

Authors:  Carlos A Vaccaro; Carlos Sarroca; Benedito Rossi; Francisco Lopez-Kostner; Mev Dominguez; Natalia Causada Calo; Raul Cutait; Adriana Della Valle; Lina Nuñez; Florencia Neffa; Karin Alvarez; Maria Laura Gonzalez; Pablo Kalfayan; Henry T Lynch; James Church
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

3.  Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.

Authors:  Erika Maria Monteiro Santos; Mev Dominguez Valentin; Felipe Carneiro; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Samuel Aguiar Junior; Wilson Toshihiko Nakagawa; Israel Gomy; Victor Evangelista de Faria Ferraz; Wilson Araujo da Silva Junior; Dirce Maria Carraro; Benedito Mauro Rossi
Journal:  BMC Cancer       Date:  2012-02-09       Impact factor: 4.430

4.  Expanding the genetic basis of copy number variation in familial breast cancer.

Authors:  Amy L Masson; Bente A Talseth-Palmer; Tiffany-Jane Evans; Desma M Grice; Garry N Hannan; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2014-05-24       Impact factor: 2.857

5.  Clinical manifestations of colorectal cancer patients from a large multicenter study in Colombia.

Authors:  Mabel Bohorquez; Ruta Sahasrabudhe; Angel Criollo; María Carolina Sanabria-Salas; Alejandro Vélez; Jorge Mario Castro; Juan Ricardo Marquez; Gilbert Mateus; Fernando Bolaños; Cesar Panqueva; Jose Ignacio Restrepo; Juan Dario Puerta; Raul Murillo; María Mercedes Bravo; Gustavo Hernández; Angela Rios; Rodrigo Prieto; Ian Tomlinson; Magdalena Echeverry; Luis G Carvajal-Carmona
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

7.  Mutation spectrum in South American Lynch syndrome families.

Authors:  Mev Dominguez-Valentin; Mef Nilbert; Patrik Wernhoff; Francisco López-Köstner; Carlos Vaccaro; Carlos Sarroca; Edenir Ines Palmero; Alejandro Giraldo; Patricia Ashton-Prolla; Karin Alvarez; Alejandra Ferro; Florencia Neffa; Junea Caris; Dirce M Carraro; Benedito M Rossi
Journal:  Hered Cancer Clin Pract       Date:  2013-12-18       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.